Early diagnosis saves lives
Median Technologies (mediantechnologies.com) scores 78 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, SaaS brands, in the 61st percentile of 6069 Healthcare brands.
Median Technologies is a healthcare technology company founded in 2019 that specializes in AI-driven medical imaging for oncology. It combines proprietary artificial intelligence, computer vision, and signal processing to convert medical imaging data into clinical insights. The company operates as an imaging contract research organization (CRO) and develops Software as a Medical Device (SaMD) solutions, serving pharmaceutical, biotech, and CRO clients involved in oncology clinical trials, with the mission of improving early cancer diagnosis and treatment.
| Brand Name | Median Technologies |
|---|---|
| Domain | mediantechnologies.com |
| Industry | Healthcare, Technology |
| Founded | 2019 |
| Main Competitors | IQVIA (85/100), ICON plc (84/100), Parexel (89/100), Radiant Sage, BioClinica (78/100), Aiforia (66/100), Paige.AI (80/100) |
Moz Domain Authority 39/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Pioneering innovative imaging services and Software as Medical Devices, we harness cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments." (Meta description: 23 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on YouTube, LinkedIn, Facebook, Instagram; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Median Technologies?", Claude could identify the brand as of September 2026. Median Technologies is a French company that provides imaging-based analytics and services for oncology clinical trials, using AI-driven imaging biomarkers to help pharmaceutical companies assess tumor response and drug efficacy. Best known for Imaging biomarker analysis and iCRO (imaging contract research organization) services for oncology clinical trials.
When asked "Best brands similar to Median Technologies?", Claude would recommend Median Technologies as of September 2026. It's a notable specialized player in medical imaging analytics for clinical trials, so it would come up naturally in discussions of imaging CROs or AI in oncology trial imaging.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Median Technologies's main competitors in Healthcare: IQVIA (85/100), ICON plc (84/100), Parexel (89/100), BioClinica (78/100), Aiforia (66/100).
Sources: Brand Analyzer scan
Median Technologies has limited AI-search visibility, scoring 30/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 39, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Median Technologies official site
Median Technologies was founded in 2019. Median Technologies operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Median Technologies offers two main types of offerings: imaging services for oncology clinical trials, which support pharmaceutical, biotech, and CRO clients in managing and analyzing medical imaging data; and Software as a Medical Device (SaMD) solutions that use AI to assist in early cancer diagnosis and treatment decisions.
Sources: Median Technologies official site
Median Technologies scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Median Technologies official site
Median Technologies harnesses proprietary AI, computer vision, and signal processing to transform medical imaging data into clinical insights. It provides imaging services for oncology clinical trials and develops Software as a Medical Device (SaMD) products aimed at improving early cancer diagnosis and treatment.
Sources: Median Technologies official site
Median Technologies can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Median Technologies official site
Median Technologies' services are used by pharmaceutical companies, biotech firms, and contract research organizations (CROs) conducting oncology clinical trials, as well as healthcare providers involved in cancer diagnosis and treatment.
Sources: Median Technologies official site
Median Technologies is a healthcare technology company, founded in 2019, that specializes in artificial intelligence-based medical imaging for oncology. It operates at the intersection of imaging services and medical device software, positioning itself as an imaging contract research organization (CRO) and an AI-driven medical device developer.
Sources: Median Technologies official site
Median Technologies scores 30/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Median Technologies has a weak AI-visibility profile at 30/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 39/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Median Technologies from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Median Technologies: Medbridge (78/100), Mosai (78/100), MedicalTourism.com (78/100), Medicover (78/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), ZOLL Data Systems (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.